Alliance CEO Criticizes MedPAC’s ‘Misguided’ 7% Home Health Payment Cut Recommendation

Why It Matters

A 7% cut could significantly reduce Medicare spending but risk shrinking home‑based care capacity, undermining access for millions of seniors. The debate highlights tensions between cost containment and preserving high‑value, patient‑centered services.

Key Takeaways

• MedPAC proposes 7% cut to home health payments.
• Cut would save $750 million in first year.
• Alliance warns cuts could close agencies, reduce access.
• MedPAC claims payments exceed costs, incentivize overuse.
• Medicare Advantage suggested as alternative cost-control mechanism.

Pulse Analysis

MedPAC’s recommendation arrives amid growing scrutiny of Medicare’s fee‑for‑service structure, which has long been criticized for inflating costs without proportional quality gains. By targeting a 7% reduction, the commission aims to align payments more closely with actual service expenditures, citing $16 billion spent on home health in 2024 for 2.7 million beneficiaries. The move reflects a broader policy shift toward curbing perceived overutilization, while positioning Medicare Advantage as a vehicle for incentivizing efficiency through capitated payments.

For home‑based care providers, the proposed cut threatens a fragile financial equilibrium. The Alliance for Care at Home warns that sustained payment reductions have already prompted agency closures, narrowed geographic coverage, and limited visit frequencies, especially in rural markets where alternatives are scarce. While MedPAC notes a 1.5% rise in agency participation, this growth is concentrated in Los Angeles County, a known hotspot for fraud, masking a 1% decline elsewhere. Stakeholders fear that further cuts could accelerate the erosion of a high‑value service that enables seniors to age in place.

Policy makers must balance fiscal responsibility with the need to preserve access to essential post‑acute care. Medicare Advantage’s per‑member‑per‑month model offers a potential pathway, yet its lower reimbursement rates could shift cost pressures onto providers already strained by fee‑for‑service cuts. As Congress weighs the recommendation, industry advocates are likely to lobby for phased adjustments, supplemental quality incentives, or targeted waivers to safeguard vulnerable populations while still pursuing the commission’s efficiency goals.